Delivery Order SPE2DB24D2101-SPE2DB24FKFZQ

Award Date 8/20/24
Potential Completion Date 8/21/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,832.59 delivery order contract is for the supply of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price type. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $9,100.00, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
This federal contract award is for the delivery of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $11,059.10 and an ultimate completion date of October 25, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated with a set-aside requirement, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $76,531.84, is for the supply of INDOCIN 50 MG SUPPOSITORY 30S, a medication used to treat various conditions. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This federal contract award is for the delivery of Indocin 50 mg suppositories to the Defense Logistics Agency (DLA). The $11,783.82 Delivery Order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 10, 2023. The contract has a firm fixed price and an ultimate completion date of May 11, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,008.03, is for the supply of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. This is not a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $26,388.00 Firm Fixed Price Delivery Order is for the supply of 4564388075 INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product. The contract has an ultimate completion date of April 25, 2024 and was awarded on April 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $8,796.00 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide INDOCIN 50 MG SUPPOSITORY 30S. This delivery order contract has a completion date of February 23, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is associated with a larger $999,999,999.00 indefinite delivery contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,183.86, is for the provision of 4567369557 INDOMETHACIN 50 MG SUPPOSITORY 30S to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,455.96, is for the delivery of 4,567,197,394 units of Indomethacin 50 mg suppositories. The contract has a firm fixed price and an ultimate completion date of February 10, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract between...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB24FKFZQ
    Delivery Order

This federal contract award, valued at $12,866.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product. This award is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is a firm fixed-price Delivery Order with an ultimate completion date of August 21, 2024.

Generated 11/19/24, 9:33 AM